Plain-English translation of NCT06498011 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The iCOSMO trial is testing a new approach to help people recover arm and hand movement after a stroke. The treatment combines two things: active touch and movement exercises during meaningful tasks, plus robotic training using a special arm device called the Kinarm Exoskeleton. The trial will compare this new approach to a standard home-based exercise program to see which works better.
Many people who have had a stroke struggle with arm and hand weakness long after they leave the hospital. This trial is testing whether combining robotic technology with specialized touch and movement training might help people regain more function than exercise alone.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups. One group receives 36 hours of the new robot-assisted therapy combined with touch training over 6 weeks, while the other group receives 36 hours of home-based exercises. You will be tested at the beginning, end, right after treatment, and again one month later to measure how well your arm and hand function improves.
AI-generated summary from trial data · Jul 13, 2026 · Not medical advice
Canada
Sponsor
University Health Network, Toronto
Collaborators
StrokeCog clinical training platform
Enrollment target
~40 participants
Started
August 2024
Primary completion
July 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Urvashy Gopaul, PhD
Toronto Rehabilitation Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.